Tracking side effects from immunotherapy using multiple tests
Part of Cancer clinical trials.
This study looks at how side effects happen in people receiving immune checkpoint inhibitor immunotherapy for solid cancers. It uses multiple types of tests to better understand these toxicities and may help improve safety and care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must sign a consent form agreeing to take part
- You must be 18 years old or older
- You must have a confirmed solid cancer diagnosis with a plan to start immune checkpoint inhibitor immunotherapy
- You cannot have a medical or mental condition that makes giving consent not possible
- You should not be planning to join another drug trial with experimental medicines
- You must not have already started immune checkpoint inhibitor therapy before joining
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what happens to your immune system after you start a type of cancer treatment called a checkpoint inhibitor. The goal is to better understand side effects related to “autoimmunity” (when the immune system starts attacking the body) and improve care.
This study looks at side effects from immunotherapy in people with solid or blood cancers. It may help doctors better manage these side effects in the future.
This study looks at side effects from immune checkpoint inhibitors in people with solid tumors. It aims to understand why side effects happen and who might be at risk, so doctors can better manage them.
This study looks at how well immunotherapy drugs (like checkpoint inhibitors) work for different cancers. If you are already planning to receive this type of treatment, researchers want to track your outcomes and see how you do over time.
This study collects blood and tumor samples to understand how well cancer immunotherapy works and what side effects may happen. It mainly helps researchers by checking “immune markers” before treatment starts, while you receive planned immune checkpoint therapy.
This study looks at how your body responds to immunotherapy and how to manage side effects. It aims to separate the treatment's benefits from its unwanted reactions.
Hear when a new Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.